SNDX icon

Syndax Pharmaceuticals

72 hedge funds and large institutions have $146M invested in Syndax Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 21 increasing their positions, 21 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 21

1.72% less ownership

Funds ownership: 63.16%61.44% (-1.7%)

Holders
72
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.6M
Puts
$1.23M
Net Calls
Net Calls Change

Top Buyers

1 +$559K
2 +$394K
3 +$358K
4
Goldman Sachs
Goldman Sachs
New York
+$345K
5
Two Sigma Investments
Two Sigma Investments
New York
+$337K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$26.7M
2
$19M
3
$15.5M
4
$15.1M
5
$11M
6
$9.39M
7
$8.23M
8
$8.12M
9
$4.35M
10
$3.87M
11
$2.63M
12
$2.19M
13
$2.12M
14
$1.86M
15
$1.58M
16
$1.15M
17
$901K
18
$895K
19
$841K
20
$783K
21
$658K
22
$559K
23
$545K
24
$530K
25
$493K